Mind and memory: a multidisciplinary exploration of Alzheimer's disease.
PDF (Português (Brasil))

Keywords

Alzheimer's disease
dementia
memory

How to Cite

Zanuto, B., Bosch, A. L., Kawaguti, B. B. N. R., Ramo, D. de F. F., Nery, D. L., Rocha, H. S., Pinho, L. A. de, Cortês, M. C., Lobo, N. S., & Melo, V. M. S. de. (2023). Mind and memory: a multidisciplinary exploration of Alzheimer’s disease. Brazilian Journal of Implantology and Health Sciences, 5(4), 1695–1709. https://doi.org/10.36557/2674-8169.2023v5n4p1695-1709

Abstract

AD is a neurodegenerative disease and is one of the leading causes of death globally, accounting for more than 4% of deaths in 2016. The dementia-related death rate from AD was more than 45 per 100,000 in a 2013 European study. The prevalence of atypical AD, most common in individuals under 65 years of age, ranges from 15-65/100,000, with some patients experiencing visual or motor difficulties, executive dysfunction, and other symptoms.

The pathogenesis of AD is linked to the presence of clusters of extracellular amyloid beta (Aβ) protein, known as neuritic plaques, and tangles of hyperphosphorylated tau proteins. These plaques are formed from amyloid precursor protein (APP) by the action of enzymes, while neurofibrillary tangles consist mainly of hyperphosphorylated tau protein.

The relationship between Aβ and tau is synergistic in neurotoxicity, with evidence that Aβ can trigger the formation of tau tangles. Biometals such as iron, copper and zinc have also been linked to AD, with dysregulation of these metals contributing to nervous system toxicity.

Genetic factors, including the APOE gene and mutations in the APP, PSEN-1, and PSEN-2 genes, also play an important role in AD. The presence of the APOE ε4 allele significantly increases the risk of developing the disease. Mutations in the APP gene are associated with an accumulation of Aβ, while mutations in PSEN-1 and PSEN-2 affect Aβ production.

Clinical manifestations include memory loss, depression, anxiety, language disorders and other cognitive and behavioral changes. The phase of AD varies from preclinical to severe, progressively affecting the patient's daily functioning.

Diagnosis combines clinical assessment, neuropsychological tests and biomarkers such as tau protein, Aβ42 and brain imaging. Treatment involves medications such as acetylcholinesterase inhibitors and memantine, as well as therapies being studied that target Aβ proteins. Healthy lifestyles, such as physical activity and diet, also play an important role in preventing and treating AD.

https://doi.org/10.36557/2674-8169.2023v5n4p1695-1709
PDF (Português (Brasil))

References

ROSA, Adrian De la et al. Physical exercise in the prevention and treatment of Alzheimer‘s disease. Journal of Sport and Health Science , [s. l.], 4 fev. 2020. DOI 10.1016/j.jshs.2020.01.004. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498620/. Acesso em: 28 ago. 2023.

RAO , Y. Lakshmisha et al. Hippocampus and its involvement in Alzheimer’s disease: a review. Biotech, [s. l.], 1 fev. 2022. DOI 10.1007/s13205-022-03123-4. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807768/. Acesso em: 28 ago. 2023.

MONFARED, Amir Abbas Tahami et al. Alzheimer’s Disease: Epidemiology and Clinical Progression. Neurology and Therapy , [s. l.], 11 jun. 2022. DOI 10.1007/s40120-022-00338-8. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095793/. Acesso em: 28 ago. 2023.

PASSERI, Elodie et al. Alzheimer‘s Disease: Treatment Strategies and Their Limitations. International Journal of Molecular Sciences, [s. l.], 23 nov. 2022. DOI 10.3390/ijms232213954. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697769/. Acesso em: 28 ago. 2023.

KHAN, Sahil et al. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Current neuropharmacology, [s. l.], 18 nov. 2020. DOI 10.2174/1570159X18666200528142429. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709159/. Acesso em: 29 ago. 2023.

LEI, Peng et al. The essential elements of Alzheimer’s disease. Journal of Biological Chemistry , [s. l.], 27 nov. 2020. DOI 10.1074/jbc.REV120.008207. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948403/. Acesso em: 31 ago. 2023.

FERRARI, Camila; SORBI, Sandro. The complexity of Alzheimer’s disease: an evolving puzzle. American physiological society, [s. l.], 24 maio 2021. DOI 10.1152/physrev.00015.2020. Disponível em: https://journals.physiology.org/doi/full/10.1152/physrev.00015.2020?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org. Acesso em: 1 set. 2023.

BREIJYEH, Zeinab; KARAMAN, Rafik. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules , [s. l.], 25 dez. 2020. DOI 10.3390/molecules25245789. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764106/. Acesso em: 1 set. 2023.

GRAFF-RADFORD, Jonathan et al. New Insights into Atypical Alzheimer’s Disease in the Era of Biomarkers. HHS Public Access, [s. l.], 20 mar. 2021. DOI 10.1016/S1474-4422(20)30440-3. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056394/. Acesso em: 1 set. 2023.

PERKOVIC, Matea Nikolac et al. Epigenetics of Alzheimer’s Disease. Biomolecules, [s. l.], 30 jan. 2021. DOI 10.3390/biom11020195. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911414/. Acesso em: 31 ago. 2023.

GUO, Tiantian et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Molecular Neurodegeneration, [s. l.], 16 jul. 2020. DOI 10.1186/s13024-020-00391-7. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364557/. Acesso em: 1 set. 2023.

KNOPMAN, David S. et al. Alzheimer disease. HHS Public Access, [s. l.], 13 maio 2021. DOI 10.1038/s41572-021-00269-y. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574196/. Acesso em: 28 ago. 2023.

JAMES, Tony et al. Locus coeruleus in memory formation and Alzheimer‘s disease. The Eupean Journal of Neuroscience, [s. l.], 27 nov. 2020. DOI 10.1111/ejn.15045. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121900/. Acesso em: 1 set. 2023.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Bruno Zanuto, Ana Luiza Bosch, Beatriz Barreira Nunes Rodrigues Kawaguti, Daiana de Freitas Ferreira Ramo, Daniela Luiz Nery, Hiago Silva Rocha, Lênio Airam de Pinho, Mychelle Christan Cortês, Nayara Silva Lobo, Victorya Machado Silva de Melo